PO-169 The Phase l/ll ACCEPT Trial: Cetuximab and IMRT with Carbon Ion Boost for Adenoid Cystic Carcinoma. (March 2019)
- Record Type:
- Journal Article
- Title:
- PO-169 The Phase l/ll ACCEPT Trial: Cetuximab and IMRT with Carbon Ion Boost for Adenoid Cystic Carcinoma. (March 2019)
- Main Title:
- PO-169 The Phase l/ll ACCEPT Trial: Cetuximab and IMRT with Carbon Ion Boost for Adenoid Cystic Carcinoma
- Authors:
- Adeberg, S.
Jensen, A.
Akbaba, S.
Katayama, S.
Verma, V.
Bernhardt, D.
Nikoghosyan, A.
Abollahi, A.
Plinkert, P.
Rieken, S.
Muenter, M.
Juergen, D. - Abstract:
- Is Part Of:
- Radiotherapy and oncology. Volume 132(2019)Supplement 1
- Journal:
- Radiotherapy and oncology
- Issue:
- Volume 132(2019)Supplement 1
- Issue Display:
- Volume 132, Issue 1 (2019)
- Year:
- 2019
- Volume:
- 132
- Issue:
- 1
- Issue Sort Value:
- 2019-0132-0001-0000
- Page Start:
- 90
- Page End:
- Publication Date:
- 2019-03
- Subjects:
- Oncology -- Periodicals
Radiotherapy -- Periodicals
Tumors -- Periodicals
Medical Oncology -- Periodicals
Neoplasms -- radiotherapy -- Periodicals
Radiotherapy -- Periodicals
Radiothérapie -- Périodiques
Cancérologie -- Périodiques
Tumeurs -- Périodiques
Electronic journals
616.9940642 - Journal URLs:
- http://www.sciencedirect.com/science/journal/01678140 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/01678140 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/01678140 ↗
http://www.estro.org/ ↗
http://www.elsevier.com/journals ↗
http://www.journals.elsevier.com/radiotherapy-and-oncology/ ↗ - DOI:
- 10.1016/S0167-8140(19)30335-4 ↗
- Languages:
- English
- ISSNs:
- 0167-8140
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 7240.790000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 9970.xml